SMAD2 promotes myogenin expression and terminal myogenic differentiation.

SMAD2 is a transcription factor, the activity of which is regulated by members of the transforming growth factor β (TGFβ) superfamily. Although activation of SMAD2 and SMAD3 downstream of TGFβ or myostatin signaling is known to inhibit myogenesis, we found that SMAD2 in the absence of TGFβ signaling promotes terminal myogenic differentiation. We found that, during myogenic differentiation, SMAD2 expression is induced. Knockout of SMAD2 expression in primary myoblasts did not affect the efficiency of myogenic differentiation but produced smaller myotubes with reduced expression of the terminal differentiation marker myogenin. Conversely, overexpression of SMAD2 stimulated myogenin expression, and enhanced both differentiation and fusion, and these effects were independent of classical activation by the TGFβ receptor complex. Loss of Smad2 in muscle satellite cells in vivo resulted in decreased muscle fiber caliber and impaired regeneration after acute injury. Taken together, we demonstrate that SMAD2 is an important positive regulator of myogenic differentiation, in part through the regulation of Myog. © 2021. Published by The Company of Biologists Ltd.

Citation

Émilie Lamarche, Hamood AlSudais, Rashida Rajgara, Dechen Fu, Saadeddine Omaiche, Nadine Wiper-Bergeron. SMAD2 promotes myogenin expression and terminal myogenic differentiation. Development (Cambridge, England). 2021 Feb 08;148(3)

Mesh Tags

Substances

PMID: 33462116

search → result